Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 26.12M
March 31, 2026 19.33M
December 31, 2025 18.23M
September 30, 2025 16.45M
June 30, 2025 18.24M
March 31, 2025 18.81M
December 31, 2024 11.98M
September 30, 2024 12.84M
June 30, 2024 15.09M
March 31, 2024 11.06M
December 31, 2023 28.90M
September 30, 2023 32.16M
June 30, 2023 18.60M
March 31, 2023 16.05M
December 31, 2022 2.892M
September 30, 2022 -5.445M
June 30, 2022 -0.1724M
March 31, 2022 -0.0024M
December 31, 2021 5.141M
September 30, 2021 6.959M
June 30, 2021 8.217M
March 31, 2021 4.592M
December 31, 2020 5.721M
September 30, 2020 9.175M
June 30, 2020 11.47M
Date Value
March 31, 2020 16.18M
December 31, 2019 14.70M
September 30, 2019 16.24M
June 30, 2019 10.61M
March 31, 2019 8.367M
December 31, 2018 4.475M
September 30, 2018 1.511M
June 30, 2018 4.223M
March 31, 2018 3.288M
December 31, 2017 4.811M
September 30, 2017 6.076M
June 30, 2017 9.820M
March 31, 2017 8.161M
December 31, 2016 8.857M
September 30, 2016 3.355M
June 30, 2016 1.041M
March 31, 2016 2.005M
December 31, 2015 1.080M
September 30, 2015 2.623M
June 30, 2015 2.255M
March 31, 2015 2.973M
December 31, 2014 4.649M
September 30, 2014 4.750M
June 30, 2014 5.862M
March 31, 2014 5.740M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Cencora, Inc. 4.821B
Abbott Laboratories 9.905B
Align Technology, Inc. 755.70M
AngioDynamics, Inc. 3.089M
Accuray, Inc. -6.981M